Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 23;46(42):11695-706.
doi: 10.1021/bi700749q. Epub 2007 Oct 2.

Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy

Affiliations

Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy

Shadi Abu-Baker et al. Biochemistry. .

Abstract

2H and 15N solid-state NMR spectroscopic techniques were used to investigate both the side chain and backbone dynamics of wild-type phospholamban (WT-PLB) and its phosphorylated form (P-PLB) incorporated into 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine (POPC) phospholipid bilayers. 2H NMR spectra of site-specific CD3-labeled WT-PLB (at Leu51, Ala24, and Ala15) in POPC bilayers were similar under frozen conditions (-25 degrees C). However, significant differences in the line shapes of the 2H NMR spectra were observed in the liquid crystalline phase at and above 0 degrees C. The 2H NMR spectra indicate that Leu51, located toward the lower end of the transmembrane (TM) helix, shows restricted side chain motion, implying that it is embedded inside the POPC lipid bilayer. Additionally, the line shape of the 2H NMR spectrum of CD3-Ala24 reveals more side chain dynamics, indicating that this residue (located in the upper end of the TM helix) has additional backbone and internal side chain motions. 2H NMR spectra of both WT-PLB and P-PLB with CD3-Ala15 exhibit strong isotropic spectral line shapes. The dynamic isotropic nature of the 2H peak can be attributed to side chain and backbone motions to residues located in an aqueous environment outside the membrane. Also, the spectra of 15N-labeled amide WT-PLB at Leu51 and Leu42 residues showed only a single powder pattern component indicating that these two 15N-labeled residues located in the TM helix are motionally restricted at 25 degrees C. Conversely, 15N-labeled amide WT-PLB at Ala11 located in the cytoplasmic domain showed both powder and isotropic components at 25 degrees C. Upon phosphorylation, the mobile component contribution increases at Ala11. The 2H and 15N NMR data indicate significant backbone motion for the cytoplasmic domain of WT-PLB when compared to the transmembrane section.

PubMed Disclaimer

Figures

Figure 1
Figure 1
High-resolution solution NMR structures as well as the corresponding sequences for (A) pentameric (bellflower-like assembly) and (B) monomeric (L-shaped) phospholamban, by the Chou (23) and Veglia (26) groups, respectively. The two structures embedded inside membrane bilayers were generated using MOL-MOL and a G5 Apple Mac computer. The three-dimensional structures in panels A and B were obtained from the Protein Data Bank.
Figure 2
Figure 2
Chemical structure of the (A) alanine and (B) leucine amino acids.
Figure 3
Figure 3
2H NMR powder pattern spectra of site-specific CD3-labeled WT-PLB and its phosphorylated form embedded inside POPC phospholipid bilayers. 2H NMR spectra are shown for (A) PLB-CD3-Leu51, (B) PLB-CD3-Ala24, (C) PLB-CD3-Ala15, and (D) P-PLB-CD3-Ala15. The experiments were conducted at temperatures ranging from -25 to 60 °C.
Figure 4
Figure 4
2H solid-state NMR spectral simulations using MXQET (55). In the generation of these spectra, rotations along the Cα-Cβ bond axis (A), the long peptide helix axis (B and C), and the Cβ-Cγ bond axis (D) were considered, and the corresponding differences in 2H NMR spectral line shapes and the quadrupolar splittings (Δν) were compared at different jumps rates. Panel A shows a 3-fold decrease in the quadrupolar splitting (Δν) when faster CD3-methyl group hopping is considered. In panel A, only the CD3-methyl group rotation about the Cα-Cβ axis was considered. Panel B shows that faster two-site exchange along the peptide helix can gradually change the 2H solid-state NMR spectral line shape from a typical Pake pattern to a bell-shaped pattern. In these simulations, the helix flips between two equally populated symmetry-related rotamers separated by 180°. This type of rotation does not affect the spectral splitting. (C) Simulation corresponding to continuous rotation along the long peptide helix which gradually changes the typical Pake pattern spectrum to an isotropic peak. In these simulations, the helix jumps among three equally populated symmetrical rotomers separated by 120°. Additionally, in panels B and C, the angle between the Cα-Cβ bond of the CD3-labeled alanine and the long helical axis of the was assumed to be 56°. (D) Simulation of the faster two-site methyl group jumping along the Cβ-Cγ bond axis of CD3-Leu that generates a bell-shaped spectrum and decreases the quadrupolar splitting (Δν). In panel D, the methyl group was tilted by 75° and jumped by 109.5°.
Figure 5
Figure 5
15N NMR powder pattern spectra of 4 mol % uniformly 15N-labeled WT-PLB (A) as well as site-specific 15N-labeled amide WT-PLB [Leu51 (B), Leu42 (C), and Ala11 (D)] and P-PLB [Ala11 (E)] proteins incorporated into POPC bilayers at 25 °C. The simulated spectra (A, D, and E) were generated by summation of its two components. The simulated spectra (B and C) were generated using one component.

Similar articles

Cited by

References

    1. Simmerman HK, Collins JH, Theibert JL, Wegener AD, Jones LR. Sequence analysis of phospholamban: Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 1986;261:13333–13341. - PubMed
    1. Simmerman HKB, Kobayashi YM, Autry JM, Jones LR. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J. Biol. Chem. 1996;271:5941–5946. - PubMed
    1. Simmerman HKB, Jones LR. Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 1998;78:921–947. - PubMed
    1. James P, Inui M, Tada M, Chiesi M, Carafoli E. Nature and site of phospholamban regulation of the calcium pump of sarcoplasmic reticulum. Nature. 1989;342:90–92. - PubMed
    1. Kirchberger MA, Tada M, Katz AM. Phospholamban a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv. Stud. Card. Struct. Metab. 1975;5:103–115. - PubMed

Publication types